[144] CeriBell, Inc. SEC Filing

Rhea-AI Filing Summary

CeriBell, Inc. (CBLL) submitted a Form 144 notice showing a proposed sale of 827 common shares acquired through restricted stock vesting on 09/01/2025. The filing lists an approximate sale date of 09/03/2025 through Fidelity Brokerage Services, with an aggregate market value of $9,394.72 based on the filing. The issuer has 36,663,968 shares outstanding, per the form. The filer also disclosed recent sales by Rebecca B. Robertson: 20,000 shares sold on 06/16/2025 for $342,737.54 and 7,445 shares sold on 06/17/2025 for $131,267.25. The filing states the securities to be sold were received as compensation and that the signer represents no undisclosed material adverse information.

Positive

• Disclosure compliance: Form 144 includes acquisition date, nature of acquisition, broker, intended sale date, and market value as required
• Transparency on prior sales: Recent sales on 06/16/2025 and 06/17/2025 are disclosed with gross proceeds
• Compensation origin disclosed: Securities to be sold were acquired through restricted stock vesting and paid as compensation

Negative

• None.

Insights

Securities Analyst

TL;DR: Small insider sale from vested restricted stock; immaterial to market capitalization but indicates owner liquidity.

The notice documents a modest proposed sale of 827 shares arising from restricted stock vesting and executed via a broker on a specified date. Given the issuer's reported 36,663,968 shares outstanding, the proposed sale represents a de minimis percentage of the float and is unlikely to move markets or affect valuation. The disclosure of prior June transactions totaling 27,445 shares provides context on recent insider cashing activity. From a compliance perspective, the Form 144 meets Rule 144 disclosure requirements by listing acquisition, payment nature, broker, and recent sales.

Corporate Governance Expert

TL;DR: Routine insider vesting and planned sale; governance impact appears limited and properly disclosed.

The filing shows shares resulting from restricted stock vesting with payment characterized as compensation and a planned sale under Rule 144. The signer’s representation regarding absence of undisclosed material adverse information is standard. Recent sales by a named individual are disclosed with gross proceeds noted, which supports transparency around insider liquidity events. No governance red flags or material insider concentration changes are evident from the data provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	827	9394.72	36663968	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2025	Restricted Stock Vesting	Issuer			827	09/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rebecca B. Robertson 360 N. Pastoria Avenue Sunnyvale CA 94085	Common	06/16/2025	20000	342737.54
Rebecca B. Robertson 360 N. Pastoria Avenue Sunnyvale CA 94085	Common	06/17/2025	7445	131267.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CeriBell (CBLL) shares are proposed for sale under this Form 144?

The filing proposes the sale of 827 common shares.

When were the 827 shares acquired and how were they acquired?

The shares were acquired on 09/01/2025 via restricted stock vesting (nature of payment: compensation).

What is the aggregate market value and planned sale date for the proposed sale?

The aggregate market value is listed as $9,394.72, with an approximate sale date of 09/03/2025 via NASDAQ through Fidelity Brokerage Services.

What insider sales has the filer reported in the past three months?

The filing discloses two prior sales by Rebecca B. Robertson: 20,000 shares on 06/16/2025 for $342,737.54, and 7,445 shares on 06/17/2025 for $131,267.25.

How large is the company's outstanding share base as reported in the filing?

The filing reports 36,663,968 shares outstanding.